1. Polyinosinic–polycytidylic acid attenuates hepatic fibrosis in C57BL/6 mice with Schistosoma japonicum infection
- Author
-
Hou, Xin, Yu, Fazhi, Man, Suqin, Huang, Dake, Zhang, Yuxia, Liu, Miao, Ren, Cuiping, and Shen, Jijia
- Subjects
- *
LIVER diseases , *SCHISTOSOMA japonicum , *LABORATORY mice , *INOSINE , *MORTALITY , *GRANULOMA - Abstract
Abstract: The development of hepatic fibrosis is the principal cause of morbidity and mortality in human beings infected with schistosoma. In this study, we investigated the effect of polyinosinic–polycytidylic acid (poly I:C) on Schistosoma japonicum (S. japonicum) egg-induced liver fibrosis. S. japonicum cercariae infected mice were injected with poly I:C at the onset of egg granuloma formation (early phase poly I:C treatment) or after the formation of liver fibrosis (late phase poly I:C treatment). Our results showed that both early and late phase poly I:C treatment significantly reduced collagen deposition and hepatic stellate cell activation in the liver. Poly I:C is one of the most effective adjuvants for Th1 type responses, and its protective effect on liver fibrosis was accompanied by increased IFN-α, IFN-β, IFN-γ, IL-12, TNF-α, and IL-10 mRNA expression, and decreased IL-4 and IL-5 mRNA expression. Moreover, poly I:C injection also enhanced the mRNA expression of natural killer group 2 member D (NKG2D) and tumor necrosis factor related apoptosis-inducing ligand (TRAIL). Therefore, it is indicated that poly I:C can significantly attenuate S. japonicum egg-induced hepatic fibrosis, which may be partly dependent on the increased Th1 response and decreased Th2 response. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF